%D8%B3%D9%84%D9%81%D8%A7%D9%85%D9%8A%D8%AB%D9%88%D9%83%D8%B3%D8%A7%D8%B2%D9%88%D9%84%D8%B3%D9%88%D9%84%D9%81%D8%A7%D9%85%D8%AA%D9%88%DA%A9%D8%B3%D8%A7%D8%B2%D9%88%D9%84Category:SulfamethoxazoleSylffamethocsasolSulfamethoxazolSulfamethoxazoleSulfametoxazol%D8%B3%D9%88%D9%84%D9%81%D8%A7%D9%85%D8%AA%D9%88%DA%A9%D8%B3%D8%A7%D8%B2%D9%88%D9%84SulfametoksatsoliSulfam%C3%A9thoxazoleSulfametossazolo%E3%82%B9%E3%83%AB%E3%83%95%E3%82%A1%E3%83%A1%E3%83%88%E3%82%AD%E3%82%B5%E3%82%BE%E3%83%BC%E3%83%ABSulfametoksazolSulfametoxazolSulfametoxazolSulfametoksazolSulfametoxazolSulfametoksazolSulfametoksazol%E0%B8%8B%E0%B8%B1%E0%B8%A5%E0%B8%9F%E0%B8%B2%E0%B9%80%E0%B8%A1%E0%B9%82%E0%B8%97%E0%B8%8B%E0%B8%B2%E0%B9%82%E0%B8%8B%E0%B8%A5%D0%A1%D1%83%D0%BB%D1%8C%D1%84%D0%B0%D0%BC%D0%B5%D1%82%D0%BE%D0%BA%D1%81%D0%B0%D0%B7%D0%BE%D0%BBSulfamethoxazoleQ415843%E7%A3%BA%E8%83%BA%E7%94%B2%E5%99%81%E5%94%91
about
sameAs
Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue InfectionsCotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus InfectionsAntimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesSulfamethoxazole Drug Interaction Study With MMX® Mesalazine/MesalamineExamination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract InfectionsInfluence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular ToxoplasmosisSeven vs. 14 Days Treatment for Male Urinary Tract InfectionPhase I Study of Safety and Immunogenicity of ADU-623Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and WarfarinRifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected AdultsAntibiotics Versus Placebo in the Treatment of Abscesses in the Emergency DepartmentSWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related LymphomaFluoroquinolone Associated DisabilityComparison of Methods for Prevention of Urinary Tract Infection Following Botox InjectionPerioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant RecipientsCulture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired AbscessDiscontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaAsymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal TransplantsEarly Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections TreatmentComparison of Topical Therapies in Post op Endoscopic Sinus Surgery PatientsCeftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) (2012-10-31)Antibiotic Prophylaxis in High-Risk Arthroplasty PatientsClindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
P4844
The use of hapten-polysaccharide conjugates for the induction of B-cell tolerance involving IgE responses. II. Specific tolerance induced by sulphonamide-substituted levan in the mouseAntigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivoInhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugsChanges in gene expression induced by tienilic Acid and sulfamethoxazole: testing the danger hypothesisUse of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9.Development of immunoassays to determinate sulfamethoxazole residues in wastewaters.Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling.Aerobic biodegradation of the sulfonamide antibiotic sulfamethoxazole by activated sludge applied as co-substrate and sole carbon and nitrogen source.Effect of lithium chloride and theophylline on hexosaminidase activity in tadpole tail discs.New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.Discovery and synthesis of a potent sulfonamide ET(B) selective antagonist.High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine.Discovery and structure-activity relationships of sulfonamide ETA-selective antagonists.Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes.Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins.In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.Differential pulse voltammetric determination and catalytic oxidation of sulfamethoxazole using [5,10,15,20- tetrakis (3-methoxy-4-hydroxy phenyl) porphyrinato] Cu (II) modified carbon paste sensor.On the effect of pharmaceuticals on bacterial nitrite oxidation.Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment.The effect of ozone on the biodegradation of 17α-ethinylestradiol and sulfamethoxazole by mixed bacterial cultures.Sulfamethoxazole abatement by means of ozonation.Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals.Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones.[Factors contributing to increases in serum creatinine following treatment with a sulfamethoxazole-trimethoprim combination product: retrospective analysis of Japanese patients with normal renal function].Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively.[Nocardia farcinica infection. Cutaneous form in an immunodepressed patient].Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.On the occasional biodegradation of pharmaceuticals in the activated sludge process: the example of the antibiotic sulfamethoxazole.A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.Synthesis and biological study of medicinally important Mannich bases derived from 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a pentahydroxy naphthacene carboxamide.QSAR model for drug human oral bioavailability.HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.Increased adsorption of sulfamethoxazole on suspended carbon nanotubes by dissolved humic acidA pilot study of safety of sulfamethoxazole, trimethoprim and guaifenesin in pediatric and adult patients with acute bronchitis
P921
Q61921246-D8BE03DA-D3EC-45F8-B59A-8510BAA73E28Q61921382-D135FAAE-BB16-43EF-A0D9-CE1B8B91F74EQ61936014-68065756-4135-44BA-9DA2-61F27878DE03Q61955758-D38436AE-84C9-479A-91CD-DCA97ED08152Q61956654-ECBB3F64-76A1-43BC-922C-B6BF00F43CFDQ61967517-864CB8B5-521F-411D-BAAC-E40DF73171C3Q61969770-503EC58A-123D-4800-B789-A9F441554821Q61975568-29035D99-D2AF-4BDE-8387-3F3DB97EC1D1Q61980654-C0D2A51C-18B8-48CE-97C8-DB6292320688Q61980717-790C93D2-613E-43AE-BB24-76DB07EB62A3Q61980865-1D7C0683-60A0-41E5-AD76-A2ACBAD9707FQ62111005-591C579B-082F-4364-94BA-943C303D3CCAQ62814462-705AB65D-C5BF-4F0B-9019-75B5F3F2615EQ62821700-D1569F98-F59E-4E9C-B42D-7A999707ABF3Q63011351-AD875D8D-6FEA-4D22-BEC8-AFD45FB94BD5Q63013213-AAC10CEC-A00C-4584-8D6D-312FD97B2015Q63316809-77915155-738F-4927-A10D-ADE30D77E855Q63318346-BBD7F7E9-374A-49F9-91FB-ACE6A4C8998CQ63321409-D4295E18-636B-4654-837D-31C4263F09D9Q63335087-D842BC7E-C6C0-487D-916F-CB323BAEA8F2Q63335286-FE89CB2C-1A92-45F0-81B6-37EBDF34EAE8Q63393940-62C6AB6E-1252-4724-81C7-5EB7BFB7E058Q63574966-1C0BBDD9-BD0F-483F-A9AE-57D93F4631A7Q86169197-AE67A5C4-58D9-4046-909B-EEB4B0A25198Q87932704-2C07F684-5641-458D-9D84-EF244A91A790Q89153157-7B46F59B-6D87-4CAC-896C-0AB945DA8403Q92193702-875BCDA1-A5E3-4E77-8884-9BCE411EC05BQ93329002-F4B970B3-054A-4274-AE9F-32FA48CF8A8A
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Sulfamethoxazol
@de
Sulfamethoxazole
@nl
Sulfametoksatsoli
@fi
Sulfametoksazol
@sh
Sulfametoksazol
@sl
Sulfametoksazol
@sr
Sulfametoxazol
@es
Sulfametoxazol
@ro
Sulfametoxazol
@sk
sulfamethoxazole
@en
type
label
Sulfamethoxazol
@de
Sulfamethoxazole
@nl
Sulfametoksatsoli
@fi
Sulfametoksazol
@sh
Sulfametoksazol
@sl
Sulfametoksazol
@sr
Sulfametoxazol
@es
Sulfametoxazol
@ro
Sulfametoxazol
@sk
sulfamethoxazole
@en
altLabel
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
@en
3-(p-aminophenylsulfonamido)-5-methylisoxazole
@en
3-Sulfanilamido-5-methylisoxazole
@en
3-sulfanilamido-5-methylisoxazole
@en
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
@en
4-amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
@cy
4-amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
@en
723-46-6
@fr
C10H11N3O3S
@fr
C10H11N3O3S1
@it
prefLabel
Sulfamethoxazol
@de
Sulfamethoxazole
@nl
Sulfametoksatsoli
@fi
Sulfametoksazol
@sh
Sulfametoksazol
@sl
Sulfametoksazol
@sr
Sulfametoxazol
@es
Sulfametoxazol
@ro
Sulfametoxazol
@sk
sulfamethoxazole
@en